无容量
医学
肿瘤科
化疗
新辅助治疗
内科学
肺癌
癌症
免疫疗法
乳腺癌
作者
Patrick M. Forde,Jonathan Spicer,Mariano Provencio,Tetsuya Mitsudomi,Mark M. Awad,Changli Wang,Shun Lu,Enriqueta Felip,Steven Swanson,Julie R. Brahmer,Keith M. Kerr,Janis M. Taube,Tudor‐Eliade Ciuleanu,Fumihiro Tanaka,Gene B. Saylors,Ke-Neng Chen,Hiroyuki Ito,Moïshe Liberman,Claudio Martín,Stephen Broderick
标识
DOI：10.1056/nejmoa2502931
摘要
Three cycles of neoadjuvant nivolumab plus chemotherapy significantly improved overall survival among patients with resectable NSCLC as compared with chemotherapy alone. (Funded by Bristol Myers Squibb; CheckMate 816 ClinicalTrials.gov number, NCT02998528.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
GingerF
无极微光
pluto
昏睡的蟠桃
ccc2
风吹麦田
iNk
小青椒
你嵙这个期刊没买
ccm
avalanche
yznfly
Frank
殷勤的紫槐
hackfeng
嘻嘻哈哈
子车茗
Tourist
小银
liao
彭于彦祖
蚊蚊爱读书
mashibeo
皖公网安备34019202002308
